17.6 C
Glasgow
Saturday, June 21, 2025
spot_img

Ooops... Error 404

Sorry, but the page you are looking for doesn't exist.

Go to the homepage

Base to Base biotech podcast 14: How to build reputation, and treating spastic paraplegia 47

biotech Jim Cornall -
This week, we have conversations with Peter Nolan, CEO of BlackFinBio, and Kim Kraemer, CEO and founder of Waterhouse Brands. Base to Base biotech podcast...

EIC Pre-Accelerator call launched to boost deeptech companies in emerging innovation regions

financing Jim Cornall -
The EIC Pre-Accelerator call is now open. Its aim is to raise SMEs’ and start-ups’ capacity to successfully apply for EIC Accelerator funding, attract private...

Time to optimise novel cell-based mRNA therapeutics reduced by more than 90%

biotech Jim Cornall -
Sensible Biotechnologies, a biotechnology company pioneering a cell-based platform for the design and manufacturing of mRNA therapeutics, today announced an initiative to accelerate the...

New hypertension pill gets FDA approval

biotech Jim Cornall -
George Medicines, a late-stage biopharmaceutical company focused on addressing unmet needs in cardiometabolic disease, has announced that the US Food and Drug Administration (FDA)...

Sofinnova Partners and NVIDIA look to accelerate European life sciences startups

biotech Jim Cornall -
Sofinnova Partners, a European life sciences venture capital firm based in Paris, London, and Milan, has announced a collaboration with NVIDIA to support its...

I-Corps Hub West accelerates deeptech commercialisation in western US

AI Jim Cornall -
I-Corps Hub West, one of the National Science Foundation's leading regional innovation hubs for academic innovations, has emerged as a critical force in transforming...

Stargardt disease targeted with $135m SpliceBio financing

biotech Jim Cornall -
SpliceBio, a clinical-stage genetic medicines company pioneering protein splicing to address diseases caused by mutations in large genes, has closed a $135m Series B...

Base to Base biotech podcast 13: Syngene commits to US market, and Nimbus Therapeutics on computational chemistry

biotech Jim Cornall -
This week, we have conversations with Dr Peter Tummino, president of R&D at Nimbus, and Alex Del Priore, senior vice president, manufacturing at Syngene...

Stay Connected

0FansLike
3,869FollowersFollow
0SubscribersSubscribe
- Advertisement -spot_img

Latest Articles

Load more

Deeptech Digest is your guide to what's new in at the cutting edge of science technology. A bit of artificial intelligence, some biotech, and all the news and latests developments in the field. If it's deeptech, it's in Deeptech Digest!

Contact us: jim@deeptechdigest.com

© 2023 Ayr Coastal Media